Get Premium to unlock powerful stock data
BUE:NVS (Switzerland)  
Novartis AG logo

Novartis AG

ARS 5232.50 (+6.57%) Jun 27
P/E:
8.34
P/B:
3.19
Market Cap:
ARS 23.53T ($ 189.38B)
Enterprise V:
ARS 25.09T ($ 201.89B)
Volume:
6.00
Avg Vol (2M):
133.00
Also Trade In:
Volume:
6.00
Market Cap ARS:
23.53T
Market Cap $:
189.38B
PE Ratio:
8.34
Avg Vol (2-Month):
133.00
Enterprise Value ARS:
25.09T
Enterprise Value $:
201.89B
PB Ratio:
3.19
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Description
Novartis AG develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The firm sells its products globally, with the United States representing close to one third of total revenue.

Financials (Next Earnings Date:2022-07-19)

BUE:NVS's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ARS) 5,307,818.169
EPS (TTM) (ARS) 2156.024
Beta 0
Volatility % 20.9
14-Day RSI 71.17
14-Day ATR (ARS) 100.494253
20-Day SMA (ARS) 4826.325
12-1 Month Momentum % 23.93
52-Week Range (ARS) 3743.5 - 5232.5
Shares Outstanding (Mil) 1,106.3

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Novartis AG Filings

Document Form Filing Date
No Filing Data